BIOX — Bioceres Crop Solutions Income Statement
0.000.00%
- $157.26m
- $154.43m
- $333.30m
Annual income statement for Bioceres Crop Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2021 June 30th | 2022 June 30th | 2023 June 30th | R2024 June 30th | 2025 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 6-K | 6-K |
Standards: | IFRS | IFRS | IFRS | — | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 207 | 328 | 415 | 465 | 333 |
Cost of Revenue | |||||
Gross Profit | 88.1 | 120 | 180 | 187 | 130 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 168 | 289 | 361 | 419 | 337 |
Operating Profit | 38.4 | 39.9 | 54.2 | 45.9 | -3.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 10.5 | 14.1 | 19.1 | 11.1 | -53.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | -3.82 | -3.91 | 20.2 | 7.3 | -55.1 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -6.87 | -7.2 | 18.8 | 4.3 | -51.7 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -6.87 | -7.2 | 18.8 | 4.3 | -51.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.222 | -0.268 | 0.291 | 0.068 | -0.838 |